Anti-PLA2R antibodies are highly specific to primary MN, however anti-PLA2R antibodies have been identified in some secondary MN such as hepatitis B (HBV) and C (HCV), use of non-steroidal anti-inflammatory drugs, solid tumor and sarcoidosis [4]. Here, PLA2R1 is linked to sarcoidosis.